Neurocognitive assessment · ADHD first
A browser-based cognitive assessment, in development, designed for clinicians to order and patients to complete at home in about 30 minutes. ADHD first, then cognitive decline.
In developmentNot FDA clearedNot for clinical use: read our regulatory statusThe continuous performance test, a core measure of sustained attention, has been studied since 1956. But a full evaluation still means a specialist, a testing room, or dedicated hardware, so most attention and memory concerns are assessed with interviews and rating scales alone.
15.5million
U.S. adults with a current ADHD diagnosis. About half were diagnosed as adults.
SourceCDC, MMWR, 2024
7.4million
Americans 65 and older living with Alzheimer's dementia in 2026.
<1 in 3
Fewer than one in three Medicare beneficiaries 65 and older in a national survey reported a structured cognitive assessment, though Medicare's Annual Wellness Visit requires detection of cognitive impairment.
Designed to run on a modern laptop or desktop. No headband, camera rig, or install. Device timing is designed to be checked in every session.
Task difficulty and length are designed to adjust to performance, so the session stays informative without running long.
Session validity first, then domain scores against normative comparisons, then the measures underneath. Designed for the clinician who ordered it.
The clinician picks a battery for the clinical question and sends the patient a link.
The patient spends about 30 minutes on tasks in a web browser at home.
Scoring and validity checks are designed to run automatically. Our target is a structured report to the clinician within 24 hours.
The clinician reads it alongside history, interview, and rating scales, and makes the call.
Designed to support a clinician's judgment. It does not diagnose.
Sample report · Synthetic data
Patient: Sample A · Adult · Session valid
1 Validity
Effort checks: passed · Device timing: within tolerance
2 Sustained attention
d′ (target sensitivity) · omissions · commissions
3 Response-time profile
RT variability · ex-Gaussian τ (slow-response tail)
4 Normative comparison
Shown against a reference band for age
Not a diagnosis. Interpret with the full clinical picture.
Illustrative sample
Validity first. Then a one-page summary by cognitive domain, with the raw measures one click deeper.
No risk score, no probability, no diagnostic label. Reference bands in this sample are synthetic.
Can the person stay on task for minutes, not seconds? Measured with a continuous performance test.
How the CPT worksd′ separates how well someone tells targets apart from how readily they press.
About d′ and criterionNot just the average: the slow tail and the trial-to-trial swings.
About RT variabilityWas the effort real? Designed to be checked in every session, before any score is shown.
About validity checks| Dimension | Interview and rating scales alone | Hardware-based attention test | Full neuropsychological evaluation | ATTNhealth (design goals) |
|---|---|---|---|---|
| Objective performance data | No. Self- and observer report | Yes, attention-focused | Yes, broad | Yes: attention, working memory, processing speed |
| Where it happens | Clinic | Clinic, or home with a camera setup | Specialist's office | Home, in a web browser |
| Equipment | None | Dedicated hardware or camera | Testing materials and a trained examiner | A laptop or desktop |
| Patient time | Minutes | Often under an hour | Often several hours | About 30 minutes |
| Effort and validity checks | Not built in | Varies | Yes, examiner-chosen | Built into every session |
| Regulatory status | n/a | Some are FDA cleared | n/a | In development. Not FDA cleared |
Who's building it
ATTNhealth's founder is an MD, PhD psychiatrist and endowed professor of psychiatry at an Ivy League medical school. He directs an adult neurodevelopment clinic, where he treats adults with ADHD, and runs a research lab that studies the genetics of neurodevelopmental and psychiatric conditions.
Academic roles are described for context only. ATTNhealth is an independent company.
Attention, working memory, processing speed.
In adults referred for ADHD evaluation.
A small group of pilot partners will see it early, help shape what the report shows, and help validate it.
Join the clinician pilotIt funds the first battery, the validation study behind it, and the start of the FDA pathway.
Request the investor deckLooking for testing for yourself or your child? ATTNhealth isn't available yet, and it will be ordered by clinicians. We can't give medical advice. If you're concerned about attention or memory, please talk with your doctor.
